Iranian Patients Suffer from Medicine Shortage
Iran is experiencing an unprecedented pharmaceutical crisis as a result of ongoing maritime and air blockades. Patients face severe shortages of many essential medicines, including cancer drugs and insulin, accompanied by rising prices and widespread black market activity. Approximately 90 types of medicines are affected, including 400 locally manufactured drugs, while the country still relies heavily on importing raw materials and auxiliary substances from abroad, further complicating the crisis. Due to sanctions and disruptions in financial exchanges, pharmaceutical companies have ceased to meet demand adequately, leading some medicines to become extremely scarce or completely unavailable. This endangers patients' lives and compels them to turn to the black market or seek treatment abroad. Estimates suggest that over 10% of pharmaceutical companies have been affected by the recent war, and the crisis is worsening due to military attacks on manufacturing sites, in addition to deteriorating financial conditions and weak supply chains. The report indicates that the government is taking measures to stockpile medicines and support domestic production, but the shortage of imported materials still threatens the sustainability of the pharmaceutical sector and leaves it vulnerable to recurrent crises.
Notice: This Is an AI-Generated Summary
Comments (0)